Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Liberum Initiates Royal Mail With Sell Rating

Thu, 07th Jan 2016 09:34

LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning:
----------
FTSE 100
----------
LIBERUM INITIATES ROYAL MAIL WITH 'SELL' - TARGET 360 PENCE
----------
UBS RAISES SAGE GROUP PRICE TARGET TO 510 (490) PENCE - 'SELL'
----------
HSBC RAISES RECKITT BENCKISER TO 'BUY' (HOLD) - PRICE TARGET 7000 (6300) PENCE
----------
EXANE BNP RAISES SMITH & NEPHEW PRICE TARGET TO 1375 (1350) P - 'OUTPERFORM'
----------
DEUTSCHE BANK RAISES HAMMERSON PRICE TARGET TO 775 (750) PENCE - 'BUY'
----------
HSBC CUTS WOLSELEY PRICE TARGET TO 4450 (4550) PENCE - 'BUY'
----------
GOLDMAN RAISES SEVERN TRENT PRICE TARGET TO 2325 (2290) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS NEXT PRICE TARGET TO 7900 (8700) PENCE - 'BUY'
----------
GOLDMAN RAISES ASTRAZENECA PRICE TARGET TO 4400 (4300) PENCE - 'NEUTRAL'
----------
SOCGEN CUTS BURBERRY PRICE TARGET TO 1250 (1300) PENCE - 'HOLD'
----------
FTSE 250
----------
BARCLAYS CUTS IMI PRICE TARGET TO 895 (1380) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS CUTS LAIRD PRICE TARGET TO 350 (370) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS CUTS ROTORK PRICE TARGET TO 170 (287) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES HALMA PRICE TARGET TO 850 (715) PENCE - 'EQUAL WEIGHT'
----------
JEFFERIES RAISES JUST EAT PRICE TARGET TO 550 (515) PENCE - 'BUY'
----------
UBS RAISES MICRO FOCUS PRICE TARGET TO 1700 (1655) PENCE - 'BUY'
----------
UBS CUTS FIDESSA GROUP TO 'NEUTRAL' ('BUY') - TARGET 2030 PENCE
----------
UBS RAISES AVEVA GROUP PRICE TARGET TO 1800 (1750) PENCE - 'BUY'
----------
BARCLAYS CUTS SPECTRIS PRICE TARGET TO 1960 (2535) PENCE - 'OVERWEIGHT'
----------
BARCLAYS CUTS QINETIQ TO 'EQUAL WEIGHT' ('OVERWEIGHT') - TARGET 270 (220) PENCE
----------
BARCLAYS CUTS RENISHAW TO 'EQUAL WEIGHT' ('OW') - TARGET 1960 (2825) PENCE
----------
CITIGROUP RAISES HOME RETAIL PRICE TARGET TO 135 PENCE - 'NEUTRAL'
----------
SOCGEN RAISES TATE & LYLE PRICE TARGET TO 700 (640) PENCE - 'BUY'
----------
GOLDMAN CUTS PENNON GROUP PRICE TARGET TO 760 (775) PENCE - 'SELL'
----------
BARCLAYS CUTS MORGAN ADVANCED MATERIALS PT TO 240 (350) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES ULTRA ELECTRONICS PT TO 1910 (1790) PENCE - 'EQUAL WEIGHT'
----------
MAIN MARKET AND AIM
----------
BARCLAYS CUTS CHEMRING GROUP PRICE TARGET TO 155 (205) PENCE - 'UNDERWEIGHT'
----------
LIBERUM RAISES SPIRENT TO 'BUY' ('HOLD') - TARGET 90 PENCE
----------
PANMURE RAISES PENNA CONSULTING PRICE TARGET TO 340 (310) PENCE - 'BUY'
----------
UBS CUTS WANDISCO PRICE TARGET TO 210 (310) PENCE - 'BUY'
----------
BARCLAYS RAISES OXFORD INSTRUMENTS PT TO 840 (750) PENCE - 'OVERWEIGHT'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more
19 Feb 2024 08:36

TOP NEWS: AstraZeneca celebrates Tagrisso approval and new data

(Alliance News) - AstraZeneca PLC on Monday announced new study data and a new approval for its cancer medication Tagrisso.

Read more
19 Feb 2024 08:03

AstraZeneca's Tagrisso gains FDA approval

(Sharecast News) - Drugmaker AstraZeneca traded higher early on Monday after revealing that a combination of its cancer drug Tagrisso with chemotherapy had gained US approval to treat a particular type of lung cancer.

Read more
19 Feb 2024 07:49

LONDON BRIEFING: MoneySupermarket credits Insurance for growth in 2023

(Alliance News) - Stocks in London are set to fall at Monday's open, as concerns over US inflation trends curb risk appetite, and damp hopes of interest rate cuts from the Federal Reserve.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.